Intermediate Protocol 100 mcg two to three times daily (morning, midday, bedtime), for 8 to 12 weeks
At present, numerous interventional strategies have demonstrated nephroprotective effects by targeting tubular cell death in DKD (173, 176, 200, 204206)
Al Qassab M, Mneimneh M, Jradi A, et al
The review notes, however, that the degree to which these benefits are independent of weight loss may vary by condition, and further research is needed to elucidate these mechanisms fully
6 But understanding barriers to bariatric surgery has the potential to improve patient outcomes, as support from healthcare providers can play a key role in motivating patients to move forward with weight loss treatment
Importantly, FOXO4-DRI showed no significant toxicity towards normal TM3 Leydig cells, demonstrating its selective action against senescent cells